HCA Healthcare, Inc. $HCA Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.0% during the 1st quarter, HoldingsChannel.com reports. The firm owned 351,897 shares of the company’s stock after selling 22,595 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in HCA Healthcare were worth $166,532,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of HCA. Sumitomo Life Insurance Co. boosted its stake in HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after purchasing an additional 20 shares during the period. MJP Associates Inc. ADV boosted its position in shares of HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after purchasing an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC increased its stake in HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after purchasing an additional 21 shares in the last quarter. Anchyra Partners LLC raised its holdings in shares of HCA Healthcare by 3.7% during the first quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after acquiring an additional 21 shares during the period. Finally, Plato Investment Management Ltd boosted its stake in HCA Healthcare by 0.6% in the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after purchasing an additional 22 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s coverage remained constructive overall, with analysts assigning the stock an average “Moderate Buy” rating, suggesting Wall Street still sees upside potential. HCA Healthcare, Inc. (NYSE:HCA) Receives Average Rating of “Moderate Buy” from Analysts
• Positive Sentiment: One commentary piece argued the recent pullback should not be seen as a fundamental breakdown, citing improving revenue, profitability, and ongoing buybacks as reasons the stock may be undervalued. HCA Healthcare’s Fall Shouldn’t Be Construed As Failing Health
• Neutral Sentiment: HCA-affiliated hospitals announced operational updates, including LewisGale Regional Health System opening a simulation center and TriStar Greenview Regional Hospital naming a new COO. These are positive for operations, but likely not major stock catalysts. LewisGale Regional Health System unveils new realistic simulation center TriStar Greenview Regional Hospital selects new Chief Operating Officer
• Neutral Sentiment: HCA’s Mission Health dropped its BSN requirement for nurses in North Carolina, a workforce-policy change that may help staffing flexibility but is unlikely to move the stock by itself. HCA’s Mission Health drops BSN requirement for nurses in North Carolina
• Negative Sentiment: Barclays reaffirmed its “equal weight” rating but cut its price target sharply to $427 from $496, which can weigh on sentiment even though the new target still implies some upside from current levels. Analyst rating update
• Negative Sentiment: A separate analyst-focused report highlighted a downgrade, reinforcing the view that some Wall Street firms are becoming less bullish on HCA after earnings. This HCA Healthcare Analyst Is No Longer Bullish
• Negative Sentiment: Post-earnings coverage questioned whether HCA should be bought, sold, or held, reflecting investor uncertainty after the latest quarterly results and contributing to cautious trading. HCA Healthcare (HCA): Buy, sell, or hold post Q1 earnings?

Analysts Set New Price Targets

A number of research firms have recently issued reports on HCA. Cantor Fitzgerald reduced their target price on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a report on Tuesday. TD Cowen dropped their price target on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Stephens lowered their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Argus dropped their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Finally, Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Fourteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $497.14.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $408.77 on Friday. The stock has a market cap of $90.68 billion, a price-to-earnings ratio of 14.06, a P/E/G ratio of 1.30 and a beta of 1.12. The firm has a fifty day moving average of $398.13 and a 200-day moving average of $460.77. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.